New rabies vaccine passes early safety check in 80 volunteers
NCT ID NCT06132789
First seen Jan 06, 2026 · Last updated Apr 28, 2026 · Updated 12 times
Summary
This study tested the safety of a new rabies vaccine in 80 healthy people aged 10 to 60. Participants received the vaccine using one of two different schedules (Essen or Zagreb). The researchers monitored for side effects for up to 6 months. The goal was to see if the vaccine is safe enough to move to larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gucheng Center for Disease Control and Prevention
Xiangyang, Hubei, China
Conditions
Explore the condition pages connected to this study.